PEMF stimulation of the vagus nerve with neorhythm: a product description and study analysis

PEMF therapy is a non-invasive technology that uses electromagnetic fields to support the body's natural processes.

Neorhythm device, developed by OmnipemF, is designed to stimulate the vagus nerve via the neck, a nerve that plays a central role in the autonomic nervous system and regulates functions such as heartbeat and relaxation. The study, conducted between 25 March 2023 and 10 January 2024, examined the effect of three frequencies-6 Hz, 16 Hz and 32 Hz-compared to a placebo group, using the neorhythm U-band. The results showed that the 16 Hz frequency resulted in significant improvements in sleep quality and general well-being, while 32 Hz was most effective for stress reduction. The report describes the unit's technical details, uses and potential benefits based on these findings, and provides a balanced presentation without indicating the treatment of specific diseases. Supplementary details from the OmnipEMF include a 60-day risk-free trial period, user satisfaction surveys and an active Facebook group with over 10,500 members.

Benefits and effects
Neorhythm can help reduce stress and concern through stimulation of the vagus nerve, which is known to influence the parasympathetic nervous system and promote peace. The study showed that the 32 Hz group achieved an average stress reduction of 23 points on the VAS scale after one month, while both 16 Hz and 32 Hz reduced concern by 15 points. Omnipemf confirms that 32 Hz is most effective for stress reduction, while both frequencies are equally effective against concern, with positive effects that are still visible a week after use. These effects can support daily well -being and help users deal with busy lifestyles.

Users have also reported increased energy and focus. One customer in a review from 19 February 2025 mentioned that Neorhythm helped focus and relax after work, while another (2nd February 2025) experienced faster sleep and better quality of sleep, which eliminated the need for supplements such as melatonin. Omnipemf emphasizes that regular use can improve vagal tone, which is linked to better general well -being, and offers "Quick Start Programs" for vagus nervous stimulation that integrates seamlessly into daily life.

The device is non-invasive and easy to use, making it accessible to people who want to integrate technology into their daily routine without complicated procedures. It does not require surgical procedures, unlike traditional vagus nervous stimulation methods, and has a favorable safety profile with few reported side effects. OMNIPEMF also offers a 60-day risk-free trial period with easy return, giving users the confidence to test the device. This, combined with positive feedback from a Facebook group with over 10,500 members and weekly Q&A sessions with Dr. Igor Jerman, makes Neorhythm an attractive alternative for those seeking non-pharmacological solutions to support their general health.

Technical specifications
The Neorhythm unit offers several potential benefits for general health and well-being, based on study results, user reports and OmnipemF's descriptions. The device can help improve sleep quality by supporting the body's natural relaxation processes. In the study, the 16 Hz group reported an average increase in sleep quality of up to 15 points on Visual Analogue Scale (VAS) after 30 days of use, indicating a very good effect on rest and recovery. This is supported by OmnipemF's website, which emphasizes that 16 Hz achieved the highest score in sleep improvement, especially on day 6, where most participants reported positive changes. This can be especially useful for people who experience sleep disorders or want deeper sleep without the use of medication.

Neorhythm U-band is a portable device designed to deliver PEMF stimulation directly to the neck, aimed at the vagus nerve. Here is a detailed overview of its technical characteristics, based on the study and OmnipemF's resources:

• Frequency selection: The unit offers three main frequencies - 6 Hz, 16 Hz and 32 Hz - which was tested in the study. 16 Hz is recommended for sleep and general well -being, while 32 Hz is most effective for stress reduction, as confirmed by Omnipemf.

• Magnetic intensity: Top intensity of 2.5 millitesla (MT), which is within safe limits of PEMF therapy and sufficient to affect nerve tissue without direct contact with the skin.

• Power source: Rechargeable battery via USB-micro (some users, who in Review from 3rd January 2025, has the desired USB-C for easier charging), with a battery life supporting multiple sessions per charging. Users report that it lasts for several days, as mentioned on 4 January 2025.

• Design: An ergonomic U-shaped band that is comfortably placed around the neck. It is light and suitable for daily use, with a weight that users describe as ideal for neck placement (5 January 2025). Neorhythm pad is a minor variant for use on other body parts.

• Control: Controlled via a mobile app, which allows users to select frequencies and customize programs. The app includes preset modes for sleep, relaxation and focus, as well as an advanced mode for custom sequences, as praised in review from 6 January 2025.

• SPEAK TIME: The study recommended 30 minutes daily, but the guidelines suggest use once or twice a day depending on needs. OMNIPEMF FAQ suggests flexible use without specific upper limit, but recommends hydration before and after sessions.

• Materials: Made of durable, skin -friendly materials, although exact specifications are not published. The package includes charging cable, reset tools and a magnetic tube for testing.

Uno Vita AS offers three design variants of neorhythm with the same technical functions, but adapted to different lifestyles: the U-band for neck use, the pad for targeted use, and a third variant (not specified in detail). 

Comprehensive and detailed description

PEMF therapy has a long history that stretches back to the 19th century, when early scientists like James L. Corning experimented with electromagnetic fields to affect the nervous system. Modern research has shown that PEMF can support cell functions, blood flow and nerve activity, making it a promising field in well -being and biohacking. Neorhythm is based on this legacy by targeting the vagus nerve, which connects the brain with many internal organs and affects parasympathetic responses such as relaxation and recovery. Omnipemf describes how the device sends targeted pulses that affect the vagus nerve's electrical signals, which can strengthen its regulation of mood, digestion and immune response.

The study, which started on March 25, 2023 and ended on 10 January 2024, is one of the largest of its kind with an initial group of 485 volunteers, although the analyzes were based on 446 respondents who completed at least one follow -up measurement. Participants were varied in age (19.8 % between 21-40 years, 50.9 % between 41-60 years, 29.5 % over 60 years) and work status (44.5 % employees, 23.9 % self-employed, self-employed, 19.3 % pensioners). About half reported existing health challenges, and two -thirds used medications or supplements, providing a broad basis for assessing the unit's effects. Prof. Dr. Igor Jerman, director of the Bion Institute, emphasizes that this is the largest global study of the PEMF on the vagus nerve, with significant improvements in sleep, relaxation and concern symptoms.

Neorhythm was used in a double-blind, placebo-controlled study where participants did not know if they received active stimulation (6 Hz, 16 Hz, 32 Hz) or placebo (0 Hz). Measurements were taken via questionnaires over five weeks, including an introductory survey, ongoing surveys (day 3, 6, 11, 16, 23, 30) and a follow -up seven days after the end. The VAS scale (0-100) was used to consider parameters such as sleep quality, general well-being, stress and concern.

The results showed clear differences between the frequencies. 16 Hz Gave the biggest improvement in general well -being (9 points average increase after 30 days) and sleep quality (15 points), especially in those with initially low wellness (VAS ≤ 50), where the increase was up to 15 points. Omnipemf confirms that 16 Hz had the highest effect on day 6 for sleep improvement. 32 Hz was most effective for stress reduction (23 points) and also reduced concern (15 points), while 6 Hz showed minimal effects and was merged with the placebo group in the analysis. The placebo group experienced moderate improvements (5 points in sleep, 11 points in concern), which can be attributed to daily relaxation alone. Long-term effects were observed seven days after termination, with the 16 Hz group maintaining the level of wellness from day 30, while stress and concern reductions began to decrease in all groups, although relative differences in placebo persisted. This is supported by the OmnipEMF, which claims that positive effects can last a week after use, indicating a sustained effect on the nervous system.
Users have reported similar experiences. A review from 14 January 2025 mentioned better sleep patterns measured with Fitbit and Withings, while another (January 13 2025) noted pain relief in bursitis and muscle problems using neorhythm pad. A customer (January 3, 2025) felt that the unit eliminated the need for sleeping medication after several months of use, indicating a potential "retreat" of the brain to relax naturally. OMNIPEMF's monthly customer satisfaction surveys (scale 1-10) provide further insight into user experiences, and their Facebook group with over 10,500 members offer a community for discussion and support, including weekly Q&A sessions with Dr. Jerman.

Neorhythm can be used in several ways:

• Sleep improvement: Place the U-band around the neck or use the pad under the 16 Hz pillow for 30 minutes before bedtime, as recommended in the study and OmnipemF's guidelines.

• Stress reduction: Use 32 Hz in 30-minute sessions, once or twice daily, as shown to be most effective in the study and confirmed by the OmnipEMF.

• Focus and Energy: Choose preset modes via the app to support mental conditions in work or meditation, as reported by an experienced meditating (January 12, 2025).

• Pain relief: Place the pad in specific areas such as hips or back, as shown in reviews from 4th and 7th January 2025, where users experienced relief of rib pain and neck rib.

To maximize the effect, regular use is recommended over at least two weeks. If the effect decreases, the guidelines suggest a break of 3-4 days before continuing. The unit requires minimal maintenance - keep it dry and clean and charge the battery when necessary. 

Disclaimer and reservation
Use of Neorhythm Should take place in consultation with qualified health professionals, especially for people with medical conditions such as heart disease or implants such as pacemakers. The unit should be kept out of reach of children. Uno Vita AS and Omnipemf do not claim that the product can diagnose, treat, cure or prevent any illness. Results can vary between individuals, and the use is intended as a supplement to general health and well -being, not as a substitute for medical treatment. Neorhythm has not been evaluated by the FDA, and users are encouraged to consult a physician by health concerns. OmnipemF FAQ confirms that the unit is safe for proper use, with recommendation for hydration to avoid minor side effects.

Freedom of speech and right to information
UNO Vita and OmnipEMF reserve the right to share publicly available research on PEMF therapy and vagus nervous stimulation in accordance with the UN Human Rights (1948), Article 19, the International Convention on Civil and Political Rights (1966), Article 19, Norwegian Constitution § 100 and the first amendment of the United States. This ensures the freedom to apply, receive and disseminate information on health and wellness technologies without state intervention, in support of users' right to knowledge.

References

• Jerman, I., škafar, M., Pihir, J., & Senica, M. (2025). Evaluating Pemf vagus nerve stimulation Through Neck Application: A Randomized Placebo Study With Volunteers. Electromagnetic Biology and Medicine. https://doi.org/10.1080/15368378.2025.2462649

• Binboğa, E., Tok, S., & Munzuroğlu, M. (2021). The Short-term Effect of Occupational Levels of 50 Hz Electromagnetic Field On Human Heart Rate Variability. Bioelectromagnetics, 42(1), 60-75. https://doi.org/10.1002/bem.22308

• Bremner, J. D., et al. (2020). Application of Noninvasive vagal nerve stimulation two stress-related psychiatric disorders. Journal of Personalized Medicine, 10 (3), E119. https://doi.org/10.3390/jpm10030119

• Ferstl, M., et al. (2021). Non-invasive vagus nerve stimulation Boosts Mood Recovery After EFFort Exertion. Psychological Medicine, 1-11. https://doi.org/10.1017/S0033291720005073

• Greco, A., & Garoli, A. (2019). Effects of Non-Focused Elf-Emf Treatment On EEG: Preliminary Study. Translational Neuroscience Research and Reviews, 2(1), 38-52. https://doi.org/10.36959/817/524

• Grote, V., et al. (2007). Short-Term Effects of Pulsed Electromagnetic Fields After Physical Exercise Are Dependent On Autonomic Tone Before Exposure. European Journal of Applied Physiology, 101(4), 495-502. https://doi.org/10.1007/s00421-007-0520-x

• Machetanz, K., et al. (2021). Transcutaneous auricular vagus nerve stimulation And Heart Rate Variability: Analysis of Parameters and Targets. Autonomic neuroscience, 236, 102894. https://doi.org/10.1016/j.autneu.2021.102894

• Mouli, S., et al. (2021). Tragus-based vagus nerve stimulation For stress reduction. Proceedings of the 14th International Joint Conference on Biomedical Engineering Systems and Technologies, 164-168. https://doi.org/10.5220/0010222201640168

• Park, S. J., et al. (2019). Physiological evaluation of a Non-invasive wearable vagus nerve stimulation (VNS) Device. International Conference on Applied Human Factors and Ergonomics, 57-62. Springs.

• Möbius, H., & Welkoborsky, H. J. (2022). Vagus nerve stimulation For conservative therapy-refractory epilepsy and depression. Laryngo-Rhino-Tologi, 101, S114-S143. https://doi.org/10.1055/a-1660-5591

• Johnson, R. L., & Wilson, C. G. (2018). A review of vagus nerve stimulation AS A Therapeutic Intervention. Journal of Inflammation Research, 11, 203-213. https://doi.org/10.2147/JIR.S163248

• Pelka, R. B., Jaenicke, C., & Gruenwald, J. (2001). Impulse magnetic-field therapy For insomnia: A double-blind, placebo-controlled study. Advances in therapy, 18(4), 174-180. https://doi.org/10.1007/BF02850111